Hyperacetylation in prostate cancer induces cell cycle aberrations, chromatin reorganization and altered gene expression profiles

Journal of Cellular and Molecular Medicine

Volumn 14, Issue 6 B, 2010, Pages 1668-1682

  Watson, Jenny A ^a,b   McKenna, Declan J ^a,c   Maxwell, Perry ^a,d   Diamond, James ^a   Arthur, Ken ^a   McKelvey Martin, Valerie J ^c   Hamilton, Peter W ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c UNIVERSITY OF ULSTER   (United Kingdom)

^d ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

Chromatin; Epigenetics; Histone acetylation; Image analysis; Prostate cancer; Trichostatin A

Indexed keywords

EID: 77955143256     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2009.00835.x     Document Type: Article

References (43)

1. Bartels PH, Montironi R, Hamilton PW. Chromatin texture signatures in nuclei from prostate lesions. Anal Quant Cytol Histol. 1998, 20:407-16.
2. Bartels PH, Montironi R, Hamilton PW. Nuclear chromatin texture in prostatic lesions. I. PIN and adenocarcinoma. Anal Quant Cytol Histol. 1998, 20:389-96.
3. Bartels PH, da Silva VD, Montironi R. Nuclear chromatin texture in prostatic lesions II: PIN and malignancy associated changes. Anal Quant Cytol Histol. 1998, 20:397-406.
4. da Silva VD, Montironi R, Thompson D. Chromatin texture in high grade prostatic intraepithelial neoplasia and early invasive carcinoma. Anal Quant Cytol Histol. 1999, 21:113-20.
5. Jia L, Shen HC, Wantroba M. Locus-wide chromatin remodeling and enhanced androgen receptor-mediated transcription in recurrent prostate tumor cells. Mol Cell Biol. 2006, 26:7331-41.
6. Allfrey VG, Faulkner R, Mirsky AE. Acetylation and methylation of histones and their possible role in the regulation of RNA synthesis. Proc Natl Acad Sci. USA. 1964, 51:786-94.
7. Turner BM. Histone acetylation and control of gene expression. J Cell Sci. 1991, 99:13-20.
8. Lee DY, Hayes JJ, Pruss D. A positive role for histone acetylation in transcription factor access to nucleosomal DNA. Cell. 1993, 72:73-84.
9. Ehrenhofer-Murray AE. Chromatin dynamics at DNA replication, transcription and repair. Eur J Biochem. 2004, 271:2335-49.
10. Lui Y, Hong Y, Zhao Y. Histone H3 (lys-9) deacetylation is associated with transcriptional silencing of E-cadherin in colorectal cancer cell lines. Cancer Invest. 2008, 26:575-82.
11. Wade PA. Transcriptional control at regulatory checkpoints by histone deacetylases: molecular connections between cancer and chromatin. Hum Mol Genet. 2001, 10:693-8.
12. De Ruijter AJ, Van Gennip AH, Caron HN. Histone deacetylases: characterization of the classical HDAC family. Biochem. 2002, J370:737-49.
13. Hoshikawa Y, Kwon HJ, Yoshida M. Trichostatin A induces morphological changes and gelsolin expression by inhibiting histone deacetylase in human carcinoma cell lines. Exp Cell Res. 1994, 214:189-97.
14. Yoshida M, Kijima M, Akita M. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J Biol Chem. 1990, 265:17174-9.
15. Vigushin DM, Ali S, Pace PE. Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo. Clin Cancer Res. 2001, 7:971-6.
16. Archer SY, Meng S, Shei A. p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells. Proc Natl Acad Sci USA. 1998, 95:6791-6.
17. Lee BI, Park SH, Kim JW. MS-275, a histone deacetylase inhibitor, selectively induces transforming growth factor beta type II receptor expression in human breast cancer cells. Cancer Res. 2001, 61:931-4.
18. Richon VM, Sandhoff TW, Rifkind RA. Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation. Proc Natl Acad Sci USA. 2000, 97:10014-9.
19. Tsubaki J, Hwa V, Twigg SM. Differential activation of the IGF binding protein-3 promoter by butyrate in prostate cancer cells. Endocrinology. 2002, 143:1778-88.
20. Roy S, Jeffery R, Tenniswood M. Array-based analysis of the effects of trichostatin A and CG-1521 on cell cycle and cell death in LNCaP prostate cancer cells. Mol Cancer Ther. 2008, 7:1931-9.
21. Taghiyev AF, Guseva NV, Glover RA. TSA-induced cell death in prostate cancer cell lines is caspase-2 dependent and involves the PIDDosome. Cancer Biol Ther. 2006, 5:e1-7.
22. Rokhlin OW, Glover RB, Guseva NV. Mechanisms of cell death induced by histone deacetylase inhibitors in androgen receptor-positive prostate cancer cells. Mol Cancer Res. 2006, 4:113-23.
23. Chicoine LG, Allis CD. Regulation of histone acetylation during macronuclear differentiation in Tetrahymena: evidence for control at the level of acetylation and deacetylation. Dev Biol. 1986, 116:477-85.
24. Zhang Y, Reinberg D. Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails. Genes Dev. 2001, 15:2343-60.
25. Mohamed MA, Greif PA, Diamond J. Epigenetic events, remodeling enzymes and their relationship to chromatin organization in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. BJU Int. 2007, 99:908-15.
26. Doudkine A, McCaulay C, Poulin N. Nuclear texture measurements in image cytometry. Pathologica. 1995, 87:286-99.
27. Haralick RM, Shanmugan K, Dinstein I. Texture features for image classification. IEEE Transactions on system, man and cybernetics. 1973, 610-21. St Louis: Elsevier Science, pp
28. Li LC, Carroll R, Dahiya R. Epigenetic changes in prostate cancer: implication for diagnosis and treatment. J Nat Cancer Instit. 2005, 97:103-14.
29. Seligson DB, Horvath S, Shi T. Global histone modification patterns predict risk of prostate cancer recurrence. Nature. 2005, 435:1262-6.
30. Huisman A, Ploeger LS, Dullens HF. Discrimination between benign and malignant prostate tissue using chromatin texture analysis in 3-D by confocal laser scanning microscopy. Prostate. 2007, 67:248-54.
31. Wang Z, Zang C, Rosenfeld JA. Combinatorial patterns of histone acetylations and methylations in the human genome. Nat Genet. 2008, 40:897-903.
32. Kim MS, Blake M, Baek JH. Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA. Cancer Res. 2003, 63:7291-300.
33. Heerdt BG, Houston MA, Mariadason JM. Dissociation of staurosporine-induced apoptosis from G2-M arrest in SW620 human colonic carcinoma cells: initiation of the apoptotic cascade is associated with elevation of the mitochondrial membrane potential (deltapsim). Cancer Res. 2000, 60:6704-13.
34. Sambucetti LC, Fischer DD, Zabludoff S. Histone deacetylase inhibition selectively alters the activity and expression of cell cycle proteins leading to specific chromatin acetylation and antiproliferative effects. J Biol Chem. 1999, 274:34940-7.
35. Siavoshian S, Segain JP, Kornprobst M. Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression. Gut. 2000, 46:507-14.
36. Strait KA, Dabbas B, Hammond EH. Cell cycle blockade and differentiation of ovarian cancer cells by the histone deacetylase inhibitor trichostatin A are associated with changes in p21, Rb, and Id proteins. Mol Cancer Ther. 2002, 1:1181-90.
37. Noh EJ, Lee JS. Functional interplay between modulation of histone deacetylase activity and its regulatory role in G2-M transition. Biochem Biophys Res Commun. 2003, 310:267-73.
38. Qiu L, Burgess A, Fairlie DP. Histone deacetylase inhibitors trigger a G2 checkpoint in normal cells that is defective in tumor cells. Mol Biol Cell. 2000, 11:2069-83.
39. Cimini D, Mattiuzzo M, Torosantucci L. Histone hyperacetylation in mitosis prevents sister chromatid separation and produces chromosome segregation defects. Mol Biol Cell. 2003, 14:3821-33.
40. Shin HJ, Baek KH, Jeon AH. Inhibition of histone deacetylase activity increases chromosomal instability by the aberrant regulation of mitotic checkpoint activation. Oncogene. 2003, 22:3853-8.
41. Prescott DM. Cellular sites of RNA synthesis. Prog Nucleic Acid Res Mol Biol. 1964, 3:33-57.
42. Gebrane-Younes J, Fomproix N, Hernandez-Verdun D. When rDNA transcription is arrested during mitosis, UBF is still associated with non-condensed rDNA. J Cell Sci. 1997, 110:2429-40.
43. Kruhlak MJ, Hendzel MJ, Fischle W. Regulation of global acetylation in mitosis through loss of histone acetyltransferases and deacetylases from chromatin. J Biol Chem. 2001, 276:38307-19.